Differentially expressed genes in EBV-infected KM-H2 compared with control cells
Gene . | Accession no. . | Mean fold change . | Ontology . |
|---|---|---|---|
| ENPP2 | L35594 | 4.16 | Cell motility, GPCR protein signaling pathway |
| CXCL12 | U19495 | 4.12 | Immune response, cell adhesion, chemotaxis, signal transduction |
| GLUL | AL161952 | 3.33 | Glutamine biosynthesis |
| SERPINA6 | NM_001756 | 3.10 | Transport |
| HMOX1 | NM_002133 | .2.87 | Positive regulation of lkB kinase/NF-kB cascade |
| CXCR4 | AJ224869 | 2.80 | Immune response, chemotaxis, GPCR protein signaling pathway |
| CCL20 | NM_004591 | 2.77 | Immune response, chemotaxis, cell-cell signaling |
| TPO | M17755 | 2.77 | Thyroid hormone generation |
| HSPA1A | NM_005345 | 2.70 | Ubiquitin-proteasome pathway, protein folding, signal transduction |
| CYP1B1 | NM_000104 | 2.55 | Eye morphogenesis |
| HAND1 | NM_004821 | 2.55 | Heart development, transcription from Pol II promoter |
| GAGE1 | NM_001472 | −2.54 | Cellular defense response |
| OAS2 | NM_016817 | −2.60 | Immune response |
| FLJ20035 | NM_017631 | −2.62 | Protein biosynthesis |
| IFI44 | NM_006417 | −2.68 | Viral response |
| ZC3HDC1 | NM_022750 | −2.72 | Nucleic acid binding |
| ITIH5 | NM_030569 | −2.95 | Regulation of localization, synthesis, and degradation of hyaluronan |
| PTPRK | NM_002844 | −2.99 | Transmembrane receptor protein tyrosine phosphatase activity |
| CALD1 | AL583520 | −3.10 | Muscle contraction and development |
| PCP4 | NM_006198 | −3.41 | Central nervous system development |
| BCHE | NM_000055 | −3.50 | Cocaine metabolism |
| CXCL11 | AF002985 | −3.60 | Immune response, chemotaxis, cell-cell signaling |
| IFIT1 | NM_001548 | −3.75 | Immune response |
| KIAA0992 | NM_016081 | −3.90 | Cell shape, adhesion, and contraction |
| Clorf29 | NM_006820 | −6.01 | Unknown |
| IFI27 | NM_005532 | −19.38 | Immune response |
Gene . | Accession no. . | Mean fold change . | Ontology . |
|---|---|---|---|
| ENPP2 | L35594 | 4.16 | Cell motility, GPCR protein signaling pathway |
| CXCL12 | U19495 | 4.12 | Immune response, cell adhesion, chemotaxis, signal transduction |
| GLUL | AL161952 | 3.33 | Glutamine biosynthesis |
| SERPINA6 | NM_001756 | 3.10 | Transport |
| HMOX1 | NM_002133 | .2.87 | Positive regulation of lkB kinase/NF-kB cascade |
| CXCR4 | AJ224869 | 2.80 | Immune response, chemotaxis, GPCR protein signaling pathway |
| CCL20 | NM_004591 | 2.77 | Immune response, chemotaxis, cell-cell signaling |
| TPO | M17755 | 2.77 | Thyroid hormone generation |
| HSPA1A | NM_005345 | 2.70 | Ubiquitin-proteasome pathway, protein folding, signal transduction |
| CYP1B1 | NM_000104 | 2.55 | Eye morphogenesis |
| HAND1 | NM_004821 | 2.55 | Heart development, transcription from Pol II promoter |
| GAGE1 | NM_001472 | −2.54 | Cellular defense response |
| OAS2 | NM_016817 | −2.60 | Immune response |
| FLJ20035 | NM_017631 | −2.62 | Protein biosynthesis |
| IFI44 | NM_006417 | −2.68 | Viral response |
| ZC3HDC1 | NM_022750 | −2.72 | Nucleic acid binding |
| ITIH5 | NM_030569 | −2.95 | Regulation of localization, synthesis, and degradation of hyaluronan |
| PTPRK | NM_002844 | −2.99 | Transmembrane receptor protein tyrosine phosphatase activity |
| CALD1 | AL583520 | −3.10 | Muscle contraction and development |
| PCP4 | NM_006198 | −3.41 | Central nervous system development |
| BCHE | NM_000055 | −3.50 | Cocaine metabolism |
| CXCL11 | AF002985 | −3.60 | Immune response, chemotaxis, cell-cell signaling |
| IFIT1 | NM_001548 | −3.75 | Immune response |
| KIAA0992 | NM_016081 | −3.90 | Cell shape, adhesion, and contraction |
| Clorf29 | NM_006820 | −6.01 | Unknown |
| IFI27 | NM_005532 | −19.38 | Immune response |
Only genes that had a positive or negative change of 2.5-fold or greater and a false discovery rate of 5% or less were included. Autotaxin is represented by its gene symbol, ENPP2.
GPCR indicates G-protein-coupled receptor.